Estados financieros detallados de Curis, Inc. (CRIS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Curis, Inc. registró ingresos de $9.4M en el último ejercicio fiscal, con un CAGR de 5 años del -2.7%.
Márgenes de los últimos 12 meses: margen bruto 99.3%, margen operativo -8.3%, margen neto -490.3%.
Al precio actual de $1.12, CRIS presenta beneficios negativos (P/E no significativo) y un ROE del -10.35%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $7.5M | $9.9M | $10.4M | $10.0M | $10.8M | $10.6M | $10.2M | $10.0M | $10.9M | $9.4M |
| Coste de Ventas | $399000 | $496000 | $563000 | $503000 | $534000 | $533000 | $257000 | $212000 | $98000 | $45000 |
| Beneficio Bruto | $7.1M | $9.4M | $9.9M | $9.5M | $10.3M | $10.1M | $9.9M | $9.8M | $10.8M | $9.4M |
| I+D | $31.6M | $33.3M | $24.4M | $22.3M | $23.1M | $34.9M | $43.3M | $39.5M | $38.6M | $28.3M |
| Generales y Administrativos | $15.6M | $25.8M | $14.8M | $11.6M | $12.1M | $17.3M | $19.6M | $18.6M | $16.8M | $14.0M |
| Gastos Operativos | $47.2M | $59.2M | $39.2M | $33.9M | $35.2M | $52.2M | $62.9M | $58.1M | $55.4M | $42.3M |
| Beneficio Operativo | -$58.0M | -$49.8M | -$29.3M | -$24.4M | -$24.9M | -$42.1M | -$53.0M | -$48.3M | -$44.5M | -$32.9M |
| EBITDA | -$57.4M | -$49.1M | -$28.5M | -$27.2M | -$24.7M | -$40.8M | -$51.7M | -$45.1M | -$42.6M | -$5.2M |
| Gastos por Intereses | $2.8M | $4.0M | $3.9M | $4.8M | $5.1M | $4.5M | $4.8M | $2.0M | $615000 | $2.2M |
| Beneficio Antes de Impuestos | -$60.4M | -$53.3M | -$32.6M | -$32.1M | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | -$7.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$60.4M | -$53.3M | -$32.6M | -$32.1M | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | -$7.6M |
| BPA | $-900.00 | $-3575.20 | $-393.40 | $-387.40 | $-245.80 | $-198.40 | $-242.80 | $-179.20 | $-137.60 | $-11.60 |
| BPA Diluido | $-900.00 | $-3575.20 | $-393.40 | $-387.40 | $-245.80 | $-198.40 | $-242.80 | $-179.20 | $-137.60 | $-11.60 |
| Acciones en Circulación (Diluidas) | $66392 | $14913 | $82795 | $82951 | $121675 | $228922 | $233481 | $264664 | $315314 | $658201 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $26.0M | $38.3M | $23.6M | $15.4M | $129.6M | $40.0M | $19.7M | $26.7M | $20.0M | $5.1M |
| Inversiones a Corto | $18.4M | $21.9M | $634000 | $5.1M | $38.9M | $75.9M | $66.0M | $29.7M | 0 | 0 |
| Cuentas por Cobrar | $2.5M | $3.1M | $2.9M | $3.2M | $3.0M | $3.2M | $3.0M | $2.8M | $3.3M | 0 |
| Inventario | -$1.3M | 0 | -$827000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $46.9M | $64.3M | $27.1M | $25.0M | $172.8M | $122.4M | $92.1M | $60.9M | $26.4M | $6.9M |
| Inmovilizado Material | $413000 | $366000 | $267000 | $303000 | $7.2M | $6.3M | $5.1M | $3.5M | $3.4M | $2.0M |
| Fondo de Comercio | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $57.8M | $73.8M | $37.4M | $35.1M | $204.4M | $162.3M | $108.8M | $77.3M | $41.3M | $20.0M |
| Cuentas por Pagar | $5.9M | $5.4M | $2.9M | $4.5M | $4.2M | $6.4M | $3.2M | $3.2M | $3.0M | $5.6M |
| Deuda a Corto | $4.9M | $5.9M | $6.9M | 0 | $557000 | 0 | 0 | 0 | 0 | $1.2M |
| Pasivos Corrientes | $8.6M | $14.1M | $6.4M | $6.5M | $10.1M | $13.4M | $10.0M | $22.0M | $19.0M | $14.1M |
| Deuda a Largo | $14.9M | $35.7M | $28.6M | 0 | $334000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $28.5M | $49.8M | $41.9M | $69.0M | $73.7M | $71.6M | $62.3M | $57.6M | $47.3M | $14.5M |
| Reservas | -$898.9M | -$952.3M | -$984.8M | -$1.02B | -$1.05B | -$1.09B | -$1.15B | -$1.20B | -$1.24B | -$1.25B |
| Patrimonio Neto | $29.3M | $24.0M | -$4.5M | -$33.9M | $130.7M | $90.7M | $46.6M | $19.7M | -$6.0M | $5.5M |
| Deuda Total | $19.9M | $41.6M | $35.5M | $166000 | $7.7M | $5.0M | $3.9M | $2.8M | $3.0M | $1.6M |
| Deuda Neta | -$24.6M | -$18.7M | $11.2M | -$20.4M | -$160.8M | -$110.8M | -$81.7M | -$53.5M | -$17.0M | -$3.4M |
| Capital Circulante | $38.3M | $50.2M | $20.8M | $18.5M | $162.7M | $108.9M | $82.1M | $38.9M | $7.4M | -$7.2M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$60.4M | -$53.3M | -$32.6M | -$32.1M | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | -$7.6M |
| Amortizaciones | $193000 | $235000 | $177000 | $125000 | $144000 | $158000 | $233000 | $255000 | $187000 | $169000 |
| Compensación en Acciones | $4.3M | $5.4M | $3.9M | $2.7M | $2.7M | $5.3M | $6.8M | $6.0M | $5.9M | $4.0M |
| Cambio en Capital Circulante | $1.9M | -$723000 | -$1.5M | -$1.6M | $1.0M | $1.0M | -$6.8M | $2.8M | -$3.7M | $1.8M |
| Flujo de Caja Operativo | -$35.8M | -$48.4M | -$30.1M | -$26.2M | -$25.7M | -$37.6M | -$54.3M | -$38.4M | -$39.6M | -$27.2M |
| Inversiones (CapEx) | -$329000 | -$188000 | -$85000 | -$41000 | -$677000 | 0 | -$416000 | 0 | 0 | 0 |
| Adquisiciones | $329000 | $188000 | $85000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$36.1M | -$48.5M | -$30.1M | -$26.2M | -$26.4M | -$37.6M | -$54.8M | -$38.4M | -$39.6M | -$27.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +31.5% | +5.4% | -4.1% | +8.3% | -1.7% | -4.6% | -1.4% | +8.8% | -13.4% | |
| Crecimiento Beneficio Neto (anual) | +11.7% | +38.9% | +1.3% | +6.9% | -51.9% | -24.7% | +16.3% | +8.5% | +82.5% | |
| Crecimiento BPA (anual) | -297.2% | +89.0% | +1.5% | +36.6% | +19.3% | -22.4% | +26.2% | +23.2% | +91.6% | |
| Cambio en Acciones (anual) | -77.5% | +455.2% | +0.2% | +46.7% | +88.1% | +2.0% | +13.4% | +19.1% | +108.7% | |
| Crecimiento FCF (anual) | -34.3% | +37.9% | +12.9% | -0.6% | -42.4% | -45.5% | +29.8% | -2.9% | +31.2% | |
| Margen Bruto | 94.7% | 95.0% | 94.6% | 95.0% | 95.1% | 95.0% | 97.5% | 97.9% | 99.1% | 99.5% |
| Margen Operativo | -771.1% | -502.7% | -281.3% | -243.5% | -229.8% | -395.0% | -521.7% | -482.2% | -408.3% | -348.4% |
| Margen EBITDA | -763.1% | -496.2% | -273.0% | -271.6% | -227.7% | -383.2% | -508.4% | -450.4% | -390.3% | -55.4% |
| Margen Neto | -802.6% | -538.7% | -312.4% | -321.3% | -276.0% | -426.7% | -557.7% | -473.0% | -397.8% | -80.3% |
| Margen FCF | -480.1% | -490.4% | -289.1% | -262.4% | -243.8% | -353.3% | -538.8% | -383.5% | -362.7% | -288.1% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-544.34 | $-3255.08 | $-364.15 | $-316.40 | $-217.10 | $-164.33 | $-234.51 | $-145.22 | $-125.47 | $-41.33 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $66392 | $14913 | $82795 | $82951 | $121675 | $228922 | $233481 | $264664 | $315314 | $658201 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -1035.26% |
| Rentabilidad sobre capital invertido | -567.17% |
| Rentabilidad sobre activos | -111.51% |
| Margen bruto | 99.28% |
| Margen operativo | -833.40% |
| Margen neto | -490.33% |
Salud financiera
| Deuda / Patrimonio | 0.22 |
| Ratio corriente | 0.49 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -92.32 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -6.84 | -0.39 | -0.70 | -1.76 | -13.33 | -9.60 | -0.91 | -1.42 | -0.44 | -1.70 |
| P/VC | 13.97 | 0.87 | -5.08 | -1.66 | 3.05 | 4.81 | 1.10 | 3.43 | -3.22 | 2.38 |
| P/V | 54.33 | 2.11 | 2.19 | 5.64 | 36.79 | 40.93 | 5.05 | 6.73 | 1.77 | 1.38 |
| Margen Bruto | 94.7% | 95.0% | 94.6% | 95.0% | 95.1% | 95.0% | 97.5% | 97.9% | 99.1% | 99.5% |
| Margen Operativo | -771.1% | -502.7% | -281.3% | -243.5% | -229.8% | -395.0% | -521.7% | -482.2% | -408.3% | -348.4% |
| Margen Neto | -802.6% | -538.7% | -312.4% | -321.3% | -276.0% | -426.7% | -557.7% | -473.0% | -397.8% | -80.3% |
Empresas relacionadas: ASBP · ATHA · BCTX · CTXR · ENTO · HOTH · ICU
Explorar sector: Healthcare · Biotechnology
Más secciones de CRIS: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones